Improving Epilepsy Programs, Services, and Outcomes through National Partnerships
The purpose of this program is to:
•Reduce the treatment gap (i.e., shortening the time to diagnosis, and increasing referral to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management);
•Increase access to appropriate health care services, community resources, and self-management supports among people with epilepsy and their families;
•Improve the public’s knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and
•Improve health, social participation, and quality of life for people with epilepsy.
General information about this opportunity
Last Known Status
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
This program is authorized under the sections 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. 241(a) and 247b(k)(2), as amended].
Who is eligible to apply/benefit from this assistance?
Open and full competition. However, to fulfill the requirements of the cooperative agreement, applicants must be able to demonstrate that their organization has specialized knowledge and experience addressing the complex and challenging health and social needs of individuals with epilepsy and their families. Applicants must also be able to demonstrate that they have the ability to work at both the national level and locally in all geographical regions of the United States (Northeast, Southeast, Middle West, Southwest, and West.).
Racial/ethnic minority groups
People with disabilities
No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles.
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. OMB Circular No. A-110
OMB Circular No. A-102
After review and approval, a Notice of Award is prepared and processed, along with appropriate notification to the public. The initial award provides funds for first budget period (12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. Applicants are encouraged to call CDC for programmatic technical assistance prior to the development and submission of their assistance application.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 90 to 120 days.
From 120 to 180 days.
How are proposals selected?
All applications will be reviewed initially for completeness by CDC PGO staff and will be reviewed jointly for eligibility by the CDC NCCDPHP and PGO. Incomplete applications and applications that do not meet the eligibility criteria will not advance to Phase II review. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the “Criteria” section of the FOA.
There may or may not be an additional review which will be provided in the FOA. Not more than thirty days after the Phase II review is completed, applicants will be notified electronically if their application does not meet eligibility or published submission requirements.
How may assistance be used?
Specific goals will be provided in a funding opportunity announcement. In general, assistance requested under this program will be used to:
•Assure a competent health professional workforce.
•Mobilize community partnerships to improve the delivery and coordination of epilepsy care.
•Inform and educate people about epilepsy, and empower people with epilepsy and their caregivers.
Funds may be used for costs associated with planning, organizing, implementing, and evaluating program elements related to the objectives identified in 050 above.
Recipients may expend funds for reasonable policies, systems, and program purposes, including personnel, travel, supplies, and services (including contractual). Recipients may not use funds for research.
Recipients may not use funds for clinical care.
Recipients may not generally use funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.
Reimbursement of pre-award costs is not allowed.
Other than for normal and recognized executive-legislative relationships, no funds may be used for:
•publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body
•the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body
The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.
Applicants must adhere to all CDC guidelines regarding allowable and unallowable expenses.
What are the requirements after being awarded this opportunity?
No program reports are required. No cash reports are required. Reporting on progress provides continuous program monitoring and identifies successes and challenges that awardees encounter throughout the project period. Also, reporting is a requirement for awardees who want to apply for yearly continuation of funding. Awardees must submit an Annual Performance Report via www.grants.gov 120 days before the end of each budget period. The report must not exceed 45 pages excluding administrative reporting; attachments are not allowed, but Web links are allowed. This report must include the following: performance measures, evaluation results, work plan, successes, challenges, CDC program support needs, and administrative reporting. The annual FFR form (SF-425) is required and must be submitted through eRA Commons within 90 days after each budget period ends. The report must include only those funds authorized and disbursed during the timeframe covered by the report. The final report must indicate the exact balance of unobligated funds, and may not reflect any unliquidated obligations. The final FFR expenditure data and the Payment Management System’s (PMS) cash transaction data must correspond; no discrepancies between the data sets are permitted. Failure to submit the required information by the due date may affect adversely the future funding of the project. If the information cannot be provided by the due date, awardees are required to submit a letter of explanation and include the date by which the information will be provided. Awardees must provide a more detailed evaluation and performance measurement plan within the first six months of the project. This more detailed plan must be developed by awardees as part of first-year project activities, with support from CDC. This more detailed plan must build on the elements stated in the initial plan, and must be no more than 25 pages. Awardees are required to submit performance measures annually as a minimum, and may require reporting more frequently. Performance measure reporting is limited to data collection. When funding is awarded initially, CDC programs will specify required reporting frequency, data fields, and format.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements. Matching is not required.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
12 budget period within a 5 year project period. Method of awarding/releasing assistance: lump sum.
Who do I contact about this opportunity?
Regional or Local Office
Maggie Moore 4770 Buford Hwy, NE, Mailstop F-78, Atlanta, Georgia 30341 Email: firstname.lastname@example.org
(Cooperative Agreements) FY 14 $0; FY 15 est $0; and FY 16 est $3,200,000 - 1 award expected for $3,200,000;.
Range and Average of Financial Assistance
1 award expected for $3,200,000;.
Regulations, Guidelines and Literature
Examples of Funded Projects